UNITEDHEALTH GROUP INC
For the period ended Dec 31, 2024. Filed Feb 27, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 27, 2025
UNH$405.12+1.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Changes in Equity
| Common Stock · Additional Paid-In Capital · Retained Earnings · Accumulated Other Comprehensive Income (Loss) · NonredeemableNoncontrolling Interests · TotalEquity | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (in millions, except per share data) · Shares · Amount · Net Unrealized Gains (Losses) on Investments · Foreign Currency Translation (Losses) Gains | ||||||||||||||
| Balance at January 1, 2022 | 941 | $10 | $— | $77,134 | $423 | $(5,807) | $3,285 | $75,045 | ||||||
| Net earnings | 20,120 | 406 | 20,526 | |||||||||||
| Other comprehensive (loss) income | (3,201) | 192 | (3,009) | |||||||||||
| Issuances of common stock, and related tax effects | 7 | — | 903 | 903 | ||||||||||
| Share-based compensation | 875 | 875 | ||||||||||||
| Common share repurchases | (14) | (1) | (1,892) | (5,107) | (7,000) | |||||||||
| Cash dividends paid on common shares ($6.40 per share) | (5,991) | (5,991) | ||||||||||||
| Redeemable noncontrolling interests fair value and other adjustments | 114 | 114 | ||||||||||||
| Acquisition and other adjustments of nonredeemable noncontrolling interests | 374 | 374 | ||||||||||||
| Distributions to nonredeemable noncontrolling interests | (387) | (387) | ||||||||||||
| Balance at December 31, 2022 | 934 | 9 | — | 86,156 | (2,778) | (5,615) | 3,678 | 81,450 | ||||||
| Net earnings | 22,381 | 575 | 22,956 | |||||||||||
| Other comprehensive income | 807 | 559 | 1,366 | |||||||||||
| Issuances of common stock, and related tax effects | 6 | — | 1,231 | 1,231 | ||||||||||
| Share-based compensation | 1,027 | 1,027 | ||||||||||||
| Common share repurchases | (16) | — | (2,057) | (6,002) | (8,059) | |||||||||
| Cash dividends paid on common shares ($7.29 per share) | (6,761) | (6,761) | ||||||||||||
| Redeemable noncontrolling interests fair value and other adjustments | (201) | (201) | ||||||||||||
| Acquisition and other adjustments of nonredeemable noncontrolling interests | 1,928 | 1,928 | ||||||||||||
| Distributions to nonredeemable noncontrolling interests | (516) | (516) | ||||||||||||
| Balance at December 31, 2023 | 924 | 9 | — | 95,774 | (1,971) | (5,056) | 5,665 | 94,421 | ||||||
| Net earnings | 14,405 | 663 | 15,068 | |||||||||||
| Other comprehensive (loss) income | (255) | 3,895 | 3,640 | |||||||||||
| Issuances of common stock, and related tax effects | 8 | — | 1,485 | 1,485 | ||||||||||
| Share-based compensation | 963 | 963 | ||||||||||||
| Common share repurchases | (17) | — | (2,395) | (6,610) | (9,005) | |||||||||
| Cash dividends paid on common shares ($8.18 per share) | (7,533) | (7,533) | ||||||||||||
| Redeemable noncontrolling interests fair value and other adjustments | (53) | (53) | ||||||||||||
| Acquisition and other adjustments of nonredeemable noncontrolling interests | 26 | 26 | ||||||||||||
| Distributions to nonredeemable noncontrolling interests | (744) | (744) | ||||||||||||
| Balance at December 31, 2024 | 915 | $9 | $— | $96,036 | $(2,226) | $(1,161) | $5,610 | $98,268 | ||||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.